Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Emma L Turner · SciRah

Researcher profile · Semantic Scholar

Emma L Turner

University of Bristol

Share profile

Emma L Turner — researcher profile on SciRah

ORCID iD 0000-0003-2575-387XHomepage

h-index: 27
Works: 81
Citations: 5,942

Most-cited papers

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
F. Hamdy, J. Donovan, J. Lane, M. Mason +23 more
2017New England Journal of Medicine2,360 citations Open access
Semantic Scholar
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
F. Hamdy, J. Donovan, J. Lane, C. Metcalfe +26 more
2023New England Journal of Medicine582 citations Open access
Semantic Scholar
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
J. Donovan, F. Hamdy, J. Lane, M. Mason +34 more
2016New England Journal of Medicine504 citations Open access
Semantic Scholar
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial
Richard M. Martin, J. Donovan, Emma L Turner, C. Metcalfe +22 more
2018Journal of the American Medical Association (JAMA)390 citations Open access
Semantic Scholar
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial.
J. Lane, J. Donovan, Michael Davis, E. Walsh +9 more
2014The Lancet Oncology248 citations Open access
Semantic Scholar
Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
J. Lane, F. Hamdy, Richard M. Martin, Emma L Turner +2 more
2010European Journal of Cancer172 citations
Semantic Scholar
“Let’s get the best quality research we can”: public awareness and acceptance of consent to use existing data in health research: a systematic review and qualitative study
E. Hill, Emma L Turner, Richard M. Martin, J. Donovan
2013BMC Medical Research Methodology144 citations Open access
Semantic Scholar
Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received.
D. Neal, C. Metcalfe, J. Donovan, J. Lane +25 more
2019European Urology141 citations Open access
Semantic Scholar
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.
Richard M. Martin, Emma L Turner, G. Young, C. Metcalfe +19 more
2024Journal of the American Medical Association (JAMA)104 citations Open access
Semantic Scholar
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
J. Lane, J. Donovan, G. Young, Michael Davis +25 more
2022BJU International87 citations Open access
Semantic Scholar
Prostate‐specific antigen testing rates remain low in UK general practice: a cross‐sectional study in six English cities
N. J. Williams, L. J. Hughes, Emma L Turner, J. Donovan +4 more
2011BJU International85 citations
Semantic Scholar
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
J. Donovan, F. Hamdy, J. Lane, G. Young +30 more
2023NEJM Evidence80 citations Open access
Semantic Scholar
Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life
A. Lane, C. Metcalfe, G. Young, T. Peters +254 more
2016BJU International68 citations Open access
Semantic Scholar
Association of diabetes mellitus with prostate cancer: Nested case–control study (Prostate testing for cancer and Treatment study)
Emma L Turner, J. Lane, J. Donovan, Michael Davis +4 more
2011International Journal of Cancer65 citations Open access
Semantic Scholar
The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
R. Bryant, J. Oxley, G. Young, J. Lane +31 more
2020BJU International55 citations Open access
Semantic Scholar
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
S. Harrison, K. Tilling, Emma L Turner, Richard M. Martin +7 more
2019Cancer Causes and Control55 citations Open access
Semantic Scholar
SIHGT and SUNOD: The role of orthography and phonology in the perception of transposed letter anagrams
C. Frankish, Emma L Turner
200752 citations
Semantic Scholar
Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee
Emma L Turner, C. Metcalfe, J. Donovan, S. Noble +25 more
2016British Journal of Cancer50 citations Open access
Semantic Scholar
Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
G. Young, S. Harrison, Emma L Turner, E. Walsh +9 more
2017BMJ Open47 citations Open access
Semantic Scholar
Validation of the Hospital Episode Statistics Outpatient Dataset in England
J. Thorn, Emma L Turner, L. Hounsome, E. Walsh +6 more
2016PharmacoEconomics (Auckland)45 citations Open access
Semantic Scholar
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
F. Hamdy, J. Donovan, J. Lane, M. Mason +32 more
2020Health Technology Assessment42 citations Open access
Semantic Scholar
The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research
S. Steginga, Emma L Turner, J. Donovan
2008World journal of urology37 citations
Semantic Scholar
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
J. Thorn, Emma L Turner, L. Hounsome, E. Walsh +7 more
2016BMJ Open34 citations Open access
Semantic Scholar
Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
Emma L Turner, C. Metcalfe, J. Donovan, S. Noble +18 more
2014British Journal of Cancer34 citations Open access
Semantic Scholar
A genetic risk score to personalize prostate cancer screening, applied to population data
M. Huynh-Le, Chun-Chieh Fan, R. Karunamuni, E. Walsh +58 more
2020Cancer Epidemiology, Biomarkers and Prevention33 citations Open access
Semantic Scholar
Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study
P. Dimitropoulou, Richard M. Martin, Emma L Turner, J. Lane +5 more
2011British Journal of Cancer30 citations Open access
Semantic Scholar
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
E. Keeney, H. Thom, Emma L Turner, Richard M. Martin +1 more
2021PharmacoEconomics (Auckland)28 citations Open access
Semantic Scholar
Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing
Sherena D Jackson, May R de la Rue, Thomas Pl Greenslade, A. M. John +4 more
2022Journal of Medical Screening26 citations Open access
Semantic Scholar
Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?
S. Harrison, K. Tilling, Emma L Turner, J. Lane +6 more
2016Cancer Causes and Control23 citations Open access
Semantic Scholar
In search of perceptual priming in a semantic classification task.
J. Bowers, Emma L Turner
2003Journal of Experimental Psychology. Learning, Memory and Cognition23 citations
Semantic Scholar
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
R. Karunamuni, M. Huynh-Le, C. Fan, W. Thompson +61 more
2021Prostate Cancer and Prostatic Diseases22 citations Open access
Semantic Scholar
Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
S. Harrison, Kate Tilling, Emma L Turner, Richard M. Martin +7 more
2020Cancer Causes and Control22 citations Open access
Semantic Scholar
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
S. Noble, K. Garfield, J. Lane, C. Metcalfe +23 more
2020British Journal of Cancer21 citations Open access
Semantic Scholar
Feasibility and cost of obtaining informed consent for essential review of medical records in large-scale health services research
S. Noble, J. Donovan, Emma L Turner, C. Metcalfe +6 more
2009Journal of Health Services Research and Policy21 citations
Semantic Scholar
Year Outcomes after Monitoring , Surgery , or Radiotherapy for Localized Prostate Cancer
F. Hamdy, J. Donovan, J. Lane, M. Mason +23 more
201620 citations
Semantic Scholar
Systematic Review of Cost-Effectiveness Models in Prostate Cancer: Exploring New Developments in Testing and Diagnosis
E. Keeney, H. Thom, Emma L Turner, Richard M. Martin +2 more
2020Value in Health19 citations Open access
Semantic Scholar
Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial
J. Lane, J. Howson, J. Donovan, J. Goepel +5 more
2007British medical journal19 citations Open access
Semantic Scholar
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
J. Donovan, G. Young, E. Walsh, C. Metcalfe +28 more
2017Journal of Clinical Epidemiology18 citations Open access
Semantic Scholar
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial
E. Keeney, S. Sanghera, Richard M. Martin, R. Gulati +9 more
2022PharmacoEconomics (Auckland)16 citations Open access
Semantic Scholar
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
S. Sanghera, S. Mohiuddin, J. Coast, K. Garfield +8 more
2020BMC Cancer16 citations Open access
Semantic Scholar
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
J. Wade, J. Donovan, A. Lane, Michael Davis +20 more
2020BMJ Open14 citations Open access
Semantic Scholar
Cross-sectional study evaluating data quality of the National Cancer Registration and Analysis Service (NCRAS) prostate cancer registry data using the Cluster randomised trial of PSA testing for Prostate cancer (CAP)
S. Merriel, Emma L Turner, E. Walsh, G. Young +7 more
2017BMJ Open14 citations Open access
Semantic Scholar
Standardisation of information submitted to an endpoint committee for cause of death assignment in a cancer screening trial – lessons learnt from CAP (Cluster randomised triAl of PSA testing for Prostate cancer)
N. J. Williams, E. Hill, S. Ng, Richard M. Martin +8 more
2015BMC Medical Research Methodology14 citations Open access
Semantic Scholar
Masked priming is abstract in the left and right visual fields.
J. Bowers, Emma L Turner
2005Brain and Language13 citations
Semantic Scholar
Ten-year mortality, disease progression and treatment-related side-effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received.
C. Metcalfe, J. Donovan, G. Young, Susan J. Dutton +6 more
201911 citations
Semantic Scholar
Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial
E. Walsh, Emma L Turner, J. Lane, J. Donovan +3 more
2016Trials9 citations Open access
Semantic Scholar
Factors associated with trial recruitment, preferences and treatments received were elucidated in a comprehensive-cohort study.
J. Donovan, B. Opmeer, G. Young, N. Mills +25 more
2019Journal of Clinical Epidemiology8 citations Open access
Semantic Scholar
Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
M. Mason, R. Moore, G. Jones, G. Lewis +253 more
2016Clinics in oncology7 citations Open access
Semantic Scholar
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS Study
J. Vassy, A. Dornisch, R. Karunamuni, M. Gatzen +61 more
2026Nature Cancer5 citations Open access
Semantic Scholar
Cancer-related morbidity at the end of life in men with prostate cancer.
Divya Yerramilli, E. Walsh, Emma L Turner, G. Young +7 more
20183 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Hamdy×36
Invite
F. Hamdy — researcher profile on SciRah
J. Donovan×31
Invite
J. Donovan — researcher profile on SciRah
J. Lane×30
Invite
J. Lane — researcher profile on SciRah
E. Walsh×29
Invite
E. Walsh — researcher profile on SciRah

×29

Invite

D. Neal — researcher profile on SciRah

C. Metcalfe×21

Invite

C. Metcalfe — researcher profile on SciRah

Richard M. Martin×18

Invite

Richard M. Martin — researcher profile on SciRah

Michael Davis×16

Invite

Michael Davis — researcher profile on SciRah

Invite

P. Bollina — researcher profile on SciRah

H. Kynaston×15

Invite

H. Kynaston — researcher profile on SciRah

Invite

A. Paul — researcher profile on SciRah

Invite

G. Young — researcher profile on SciRah